Lung disease in systemic sclerosis (scleroderma)
- 1 February 1993
- journal article
- Published by Elsevier in Bailliere's Clinical Rheumatology
- Vol. 7 (1) , 79-97
- https://doi.org/10.1016/s0950-3579(05)80269-9
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Retrospective Studies in Scleroderma: Pulmonary Findings and Effect of Potassium p-Aminobenzoate on Vital CapacityRespiration, 1989
- A multisystemic disease caused by adulterated rapeseed oilBrain & Development, 1988
- CREST SyndromeSouthern Medical Journal, 1988
- Clinical, pathologic, and immunopathologic manifestations of the toxic oil syndrome: Analysis of fourteen casesJournal of the American Academy of Dermatology, 1988
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases.Thorax, 1988
- Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma.Heart, 1982
- Echocardiographic features of progressive systemic sclerosis (PSS)The American Journal of Medicine, 1979
- Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosisChest, 1976
- Respiratory Function in Progressive Systemic SclerosisThorax, 1963